miR-99 family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation

Dandan Sun, Yong Sun Lee, Ankit Malhotra, Hak Kyun Kim, Mirela Matecic, Clive Evans, Roderick V. Jensen, Christopher A. Moskaluk, Anindya Dutta

Research output: Contribution to journalArticle

159 Citations (Scopus)

Abstract

MicroRNAs (miRNA) have been globally profiled in cancers but there tends to be poor agreement between studies including in the same cancers. In addition, few putative miRNA targets have been validated. To overcome the lack of reproducibility, we profiled miRNAs by next generation sequencing and locked nucleic acid miRNA microarrays and verified concordant changes by quantitative RT-PCR. Notably, miR-125b and the miR-99 family members miR-99a, -99b, and -100 were downregulated in all assays in advanced prostate cancer cell lines relative to the parental cell lines from which they were derived. All four miRNAs were also downregulated in human prostate tumor tissue compared with normal prostate. Transfection of miR-99a, -99b, or -100 inhibited the growth of prostate cancer cells and decreased the expression of prostate-specific antigen (PSA), suggesting potential roles as tumor suppressors in this setting. To identify targets of these miRNAs, we combined computational prediction of potential targets with experimental validation by microarray and polyribosomal loading analysis. Three direct targets of the miR-99 family that were validated in this manner were the chromatin-remodeling factors SMARCA5 and SMARCD1 and the growth regulatory kinase mTOR. We determined that PSA is posttranscriptionally regulated by the miR-99 family members, at least partially, by repression of SMARCA5. Together, our findings suggest key functions and targets of miR-99 family members in prostate cancer suppression and prognosis.

Original languageEnglish (US)
Pages (from-to)1313-1324
Number of pages12
JournalCancer Research
Volume71
Issue number4
DOIs
StatePublished - Feb 15 2011
Externally publishedYes

Fingerprint

Prostate-Specific Antigen
MicroRNAs
Prostatic Neoplasms
Cell Proliferation
Prostate
Neoplasms
Down-Regulation
Cell Line
Chromatin Assembly and Disassembly
Growth
Transfection
Phosphotransferases
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

miR-99 family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. / Sun, Dandan; Lee, Yong Sun; Malhotra, Ankit; Kim, Hak Kyun; Matecic, Mirela; Evans, Clive; Jensen, Roderick V.; Moskaluk, Christopher A.; Dutta, Anindya.

In: Cancer Research, Vol. 71, No. 4, 15.02.2011, p. 1313-1324.

Research output: Contribution to journalArticle

Sun, D, Lee, YS, Malhotra, A, Kim, HK, Matecic, M, Evans, C, Jensen, RV, Moskaluk, CA & Dutta, A 2011, 'miR-99 family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation', Cancer Research, vol. 71, no. 4, pp. 1313-1324. https://doi.org/10.1158/0008-5472.CAN-10-1031
Sun, Dandan ; Lee, Yong Sun ; Malhotra, Ankit ; Kim, Hak Kyun ; Matecic, Mirela ; Evans, Clive ; Jensen, Roderick V. ; Moskaluk, Christopher A. ; Dutta, Anindya. / miR-99 family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. In: Cancer Research. 2011 ; Vol. 71, No. 4. pp. 1313-1324.
@article{f7ef6afb5de748588f372dfe6d68471c,
title = "miR-99 family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation",
abstract = "MicroRNAs (miRNA) have been globally profiled in cancers but there tends to be poor agreement between studies including in the same cancers. In addition, few putative miRNA targets have been validated. To overcome the lack of reproducibility, we profiled miRNAs by next generation sequencing and locked nucleic acid miRNA microarrays and verified concordant changes by quantitative RT-PCR. Notably, miR-125b and the miR-99 family members miR-99a, -99b, and -100 were downregulated in all assays in advanced prostate cancer cell lines relative to the parental cell lines from which they were derived. All four miRNAs were also downregulated in human prostate tumor tissue compared with normal prostate. Transfection of miR-99a, -99b, or -100 inhibited the growth of prostate cancer cells and decreased the expression of prostate-specific antigen (PSA), suggesting potential roles as tumor suppressors in this setting. To identify targets of these miRNAs, we combined computational prediction of potential targets with experimental validation by microarray and polyribosomal loading analysis. Three direct targets of the miR-99 family that were validated in this manner were the chromatin-remodeling factors SMARCA5 and SMARCD1 and the growth regulatory kinase mTOR. We determined that PSA is posttranscriptionally regulated by the miR-99 family members, at least partially, by repression of SMARCA5. Together, our findings suggest key functions and targets of miR-99 family members in prostate cancer suppression and prognosis.",
author = "Dandan Sun and Lee, {Yong Sun} and Ankit Malhotra and Kim, {Hak Kyun} and Mirela Matecic and Clive Evans and Jensen, {Roderick V.} and Moskaluk, {Christopher A.} and Anindya Dutta",
year = "2011",
month = "2",
day = "15",
doi = "10.1158/0008-5472.CAN-10-1031",
language = "English (US)",
volume = "71",
pages = "1313--1324",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - miR-99 family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation

AU - Sun, Dandan

AU - Lee, Yong Sun

AU - Malhotra, Ankit

AU - Kim, Hak Kyun

AU - Matecic, Mirela

AU - Evans, Clive

AU - Jensen, Roderick V.

AU - Moskaluk, Christopher A.

AU - Dutta, Anindya

PY - 2011/2/15

Y1 - 2011/2/15

N2 - MicroRNAs (miRNA) have been globally profiled in cancers but there tends to be poor agreement between studies including in the same cancers. In addition, few putative miRNA targets have been validated. To overcome the lack of reproducibility, we profiled miRNAs by next generation sequencing and locked nucleic acid miRNA microarrays and verified concordant changes by quantitative RT-PCR. Notably, miR-125b and the miR-99 family members miR-99a, -99b, and -100 were downregulated in all assays in advanced prostate cancer cell lines relative to the parental cell lines from which they were derived. All four miRNAs were also downregulated in human prostate tumor tissue compared with normal prostate. Transfection of miR-99a, -99b, or -100 inhibited the growth of prostate cancer cells and decreased the expression of prostate-specific antigen (PSA), suggesting potential roles as tumor suppressors in this setting. To identify targets of these miRNAs, we combined computational prediction of potential targets with experimental validation by microarray and polyribosomal loading analysis. Three direct targets of the miR-99 family that were validated in this manner were the chromatin-remodeling factors SMARCA5 and SMARCD1 and the growth regulatory kinase mTOR. We determined that PSA is posttranscriptionally regulated by the miR-99 family members, at least partially, by repression of SMARCA5. Together, our findings suggest key functions and targets of miR-99 family members in prostate cancer suppression and prognosis.

AB - MicroRNAs (miRNA) have been globally profiled in cancers but there tends to be poor agreement between studies including in the same cancers. In addition, few putative miRNA targets have been validated. To overcome the lack of reproducibility, we profiled miRNAs by next generation sequencing and locked nucleic acid miRNA microarrays and verified concordant changes by quantitative RT-PCR. Notably, miR-125b and the miR-99 family members miR-99a, -99b, and -100 were downregulated in all assays in advanced prostate cancer cell lines relative to the parental cell lines from which they were derived. All four miRNAs were also downregulated in human prostate tumor tissue compared with normal prostate. Transfection of miR-99a, -99b, or -100 inhibited the growth of prostate cancer cells and decreased the expression of prostate-specific antigen (PSA), suggesting potential roles as tumor suppressors in this setting. To identify targets of these miRNAs, we combined computational prediction of potential targets with experimental validation by microarray and polyribosomal loading analysis. Three direct targets of the miR-99 family that were validated in this manner were the chromatin-remodeling factors SMARCA5 and SMARCD1 and the growth regulatory kinase mTOR. We determined that PSA is posttranscriptionally regulated by the miR-99 family members, at least partially, by repression of SMARCA5. Together, our findings suggest key functions and targets of miR-99 family members in prostate cancer suppression and prognosis.

UR - http://www.scopus.com/inward/record.url?scp=79951828224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951828224&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-1031

DO - 10.1158/0008-5472.CAN-10-1031

M3 - Article

VL - 71

SP - 1313

EP - 1324

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 4

ER -